Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Study:

Screening for Lung Cancer

Public Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Study: Screening for Lung Cancer

The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement, draft evidence review, and draft modeling study on screening for lung cancer. The Task Force found new evidence that shows screening can help more people at high risk. The draft recommendation statement, draft evidence review, and draft modeling study are available for review and public comment from July 7, 2020 to August 3, 2020 here.

The Draft Recommendation Statement and Draft Evidence Review Are Open to Public Comment

COMMENTING DETAILS

Public Comment Period:

7/7/20 - 8/3/20

Any visitor to the Task Force website can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population

Recommendation

Grade

Adults ages 50 to 80 years who have a 20 pack-year smoking history, currently smoke, or have quit within the past 15 years

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults ages 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.

See the full draft recommendation statement